Arriola E - Search Results

1

Pre-existing tumor host immunity characterization in resected non-small cell lung cancer.

Rocha P, Rodrigo M, Moliner L, Menendez S, Masfarré L, Navarro N, Del Rey-Vergara R, Galindo-Campos M, Taus Á, Giner M, Sanchez I, Rodríguez-Fuster A, Aguiló R, Chalela R, Sánchez-Font A, Belda J, Curull V, Pijuan L, Casadevall D, Clavé S, Bellosillo B, Perera-Bel J, Comerma L, Arriola E. Rocha P, et al. Among authors: arriola e. Lung Cancer. 2023 Jul;181:107257. doi: 10.1016/j.lungcan.2023.107257. Epub 2023 May 20. Lung Cancer. 2023. PMID: 37263182

2

Cutaneous recall phenomenon with vinorelbine.

Gómez-Ulloa D, Bundó AV, Antonio JM, Arriola E, Conde-Estévez D. Gómez-Ulloa D, et al. Among authors: arriola e. Ann Pharmacother. 2011 Sep;45(9):1168-9. doi: 10.1345/aph.1Q279. Epub 2011 Aug 23. Ann Pharmacother. 2011. PMID: 21862715 No abstract available.

3

Predictive value of HER-2 and Topoisomerase IIalpha in response to primary doxorubicin in breast cancer.

Arriola E, Moreno A, Varela M, Serra JM, Falo C, Benito E, Escobedo AP. Arriola E, et al. Eur J Cancer. 2006 Nov;42(17):2954-60. doi: 10.1016/j.ejca.2006.06.013. Epub 2006 Aug 28. Eur J Cancer. 2006. PMID: 16935488

4

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.

Arriola E, Marchio C, Tan DS, Drury SC, Lambros MB, Natrajan R, Rodriguez-Pinilla SM, Mackay A, Tamber N, Fenwick K, Jones C, Dowsett M, Ashworth A, Reis-Filho JS. Arriola E, et al. Lab Invest. 2008 May;88(5):491-503. doi: 10.1038/labinvest.2008.19. Epub 2008 Mar 10. Lab Invest. 2008. PMID: 18332872 Free article.

5

Response to neoadjuvant therapy for rectal cancer: influence on long-term results.

Biondo S, Navarro M, Marti-Rague J, Arriola E, Pares D, Del Rio C, Cambray M, Novell V. Biondo S, et al. Among authors: arriola e. Colorectal Dis. 2005 Sep;7(5):472-9. doi: 10.1111/j.1463-1318.2005.00864.x. Colorectal Dis. 2005. PMID: 16108884

6

Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation.

Arriola E, Lambros MB, Jones C, Dexter T, Mackay A, Tan DS, Tamber N, Fenwick K, Ashworth A, Dowsett M, Reis-Filho JS. Arriola E, et al. Lab Invest. 2007 Jan;87(1):75-83. doi: 10.1038/labinvest.3700495. Lab Invest. 2007. PMID: 17170740 Free article.

7

Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.

Duran M, Pérez E, Abanades S, Vidal X, Saura C, Majem M, Arriola E, Rabanal M, Pastor A, Farré M, Rams N, Laporte JR, Capellà D. Duran M, et al. Among authors: arriola e. Br J Clin Pharmacol. 2010 Nov;70(5):656-63. doi: 10.1111/j.1365-2125.2010.03743.x. Br J Clin Pharmacol. 2010. PMID: 21039759 Free PMC article. Clinical Trial.

8

Imaging techniques contribute to increased surgical rescue of relapse in the follow-up of colorectal cancer.

Arriola E, Navarro M, Parés D, Muñoz M, Pareja L, Figueras J, Soler G, Martinez M, Majem M, Germa-Lluch JR. Arriola E, et al. Dis Colon Rectum. 2006 Apr;49(4):478-84. doi: 10.1007/s10350-005-0280-9. Dis Colon Rectum. 2006. PMID: 16450212

9

Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.

Arriola EL, Lopez AR, Chresta CM. Arriola EL, et al. Oncogene. 1999 Jan 28;18(4):1081-91. doi: 10.1038/sj.onc.1202391. Oncogene. 1999. PMID: 10023685

10

p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.

Luna-Perez P, Arriola EL, Cuadra Y, Alvarado I, Quintero A. Luna-Perez P, et al. Among authors: arriola el. Ann Surg Oncol. 1998 Apr-May;5(3):203-8. doi: 10.1007/BF02303772. Ann Surg Oncol. 1998. PMID: 9607618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page